China Biologic Products - 48 Year Dividend Yield History | CBPO

Historical dividend payout and yield for China Biologic Products (CBPO) since 1971. The current TTM dividend payout for China Biologic Products (CBPO) as of February 20, 2019 is $0.00. The current dividend yield for China Biologic Products as of February 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.666B $0.370B
China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Bio-Techne Corp (TECH) United States $7.246B 48.82